Table 2.
Plasma concentrations (medians with ranges) for methoxytyramine, normetanephrine and metanephrine across the reference population.
n | Age, median | Methoxytyramine (nmol/L) | Normetanephrine (nmol/L) | Metanephrine (nmol/L) | |
---|---|---|---|---|---|
All subjects | 423 | 45 | 0.028 (0.008–0.100) | 0.340 (0.129–1.055) | 0.151 (0.030–0.449) |
Women | 238 | 45 | 0.027 (0.008–0.078) | 0.336 (0.129–0.946) | 0.135 (0.030–0.449) |
Men | 185 | 46 | 0.029 (0.009–0.100)* | 0.342 (0.156–1.055) | 0.176 (0.058–0.405)** |
18–29 years | 83 | 25 | 0.026 (0.008–0.063) | 0.281 (0.129–0.580) | 0.138 (0.030–0.264) |
30–39 years | 65 | 35 | 0.028 (0.014–0.089) | 0.301 (0.129–0.698) | 0.139 (0.047–0.334) |
40–49 years | 116 | 45 | 0.028 (0.014–0.078) | 0.320 (0.136–0.788) | 0.151 (0.059–0.449) |
50–59 years | 100 | 54 | 0.024 (0.008–0.100) | 0.368 (0.174–0.873) | 0.164 (0.053–0.405) |
>60 years | 59 | 63 | 0.031 (0.014–0.065) | 0.383 (0.156–1.055) | 0.159 (0.037–0.329) |
Normotensive | 161 | 37 | 0.028 (0.008–0.100)¥ | 0.288 (0.129–0.788)¥¥ | 0.141 (0.042–0.449)¥ |
Hypertensive | 262 | 50 | 0.029 (0.009–0.088) | 0.362 (0.129–1.055) | 0.161 (0.030–0.405) |
Indicates difference (P = 0.0031) between men and women; **indicates difference (P < 0.001) between men and women; ¥indicates difference (P < 0.05) between normotensive and hypertensive subjects; ¥¥indicates difference (P < 0.0001) between normotensive and hypertensive subjects.